228 related articles for article (PubMed ID: 22031624)
1. UDP-glucuronosyltransferase expression in mouse liver is increased in obesity- and fasting-induced steatosis.
Xu J; Kulkarni SR; Li L; Slitt AL
Drug Metab Dispos; 2012 Feb; 40(2):259-66. PubMed ID: 22031624
[TBL] [Abstract][Full Text] [Related]
2. Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2.
Buckley DB; Klaassen CD
Drug Metab Dispos; 2009 Apr; 37(4):847-56. PubMed ID: 19144771
[TBL] [Abstract][Full Text] [Related]
3. Induction of rat UDP-glucuronosyltransferases in liver and duodenum by microsomal enzyme inducers that activate various transcriptional pathways.
Shelby MK; Klaassen CD
Drug Metab Dispos; 2006 Oct; 34(10):1772-8. PubMed ID: 16855052
[TBL] [Abstract][Full Text] [Related]
4. Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet.
Osabe M; Sugatani J; Fukuyama T; Ikushiro S; Ikari A; Miwa M
Drug Metab Dispos; 2008 Feb; 36(2):294-302. PubMed ID: 17967931
[TBL] [Abstract][Full Text] [Related]
5. The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure.
Court MH; Freytsis M; Wang X; Peter I; Guillemette C; Hazarika S; Duan SX; Greenblatt DJ; Lee WM;
J Pharmacol Exp Ther; 2013 May; 345(2):297-307. PubMed ID: 23408116
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of Human Hepatic Uridine Diphosphate Glucuronosyltransferase Proteins: Implications for Ontogenetic Mechanisms and Isoform Coregulation.
Liu Y; Badée J; Takahashi RH; Schmidt S; Parrott N; Fowler S; Mackenzie PI; Coughtrie MWH; Collier AC
J Clin Pharmacol; 2020 Jun; 60(6):722-733. PubMed ID: 31879975
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome association analysis identifies miR-375 as a major determinant of variable acetaminophen glucuronidation by human liver.
Papageorgiou I; Freytsis M; Court MH
Biochem Pharmacol; 2016 Oct; 117():78-87. PubMed ID: 27531059
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.
Mutlib AE; Goosen TC; Bauman JN; Williams JA; Kulkarni S; Kostrubsky S
Chem Res Toxicol; 2006 May; 19(5):701-9. PubMed ID: 16696573
[TBL] [Abstract][Full Text] [Related]
9. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
10. Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-null mice.
Aleksunes LM; Klaassen CD
Drug Metab Dispos; 2012 Jul; 40(7):1366-79. PubMed ID: 22496397
[TBL] [Abstract][Full Text] [Related]
11. Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease.
Hardwick RN; Ferreira DW; More VR; Lake AD; Lu Z; Manautou JE; Slitt AL; Cherrington NJ
Drug Metab Dispos; 2013 Mar; 41(3):554-61. PubMed ID: 23223517
[TBL] [Abstract][Full Text] [Related]
12. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
[TBL] [Abstract][Full Text] [Related]
13. Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha.
Ding X; Lichti K; Kim I; Gonzalez FJ; Staudinger JL
J Biol Chem; 2006 Sep; 281(36):26540-51. PubMed ID: 16825189
[TBL] [Abstract][Full Text] [Related]
14. Expression of hepatic cytochrome P450s and UDP-glucuronosyltransferases in PXR and CAR double humanized mice treated with rifampicin.
Lee SY; Lee JY; Kim YM; Kim SK; Oh SJ
Toxicol Lett; 2015 Jun; 235(2):107-15. PubMed ID: 25835148
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Sweated and Non-Sweated Ethanol Extracts of
Liu J; Shi Y; Wu C; Hong B; Peng D; Yu N; Wang G; Wang L; Chen W
Curr Drug Metab; 2022; 23(6):473-483. PubMed ID: 35585828
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme.
Barbier O; Duran-Sandoval D; Pineda-Torra I; Kosykh V; Fruchart JC; Staels B
J Biol Chem; 2003 Aug; 278(35):32852-60. PubMed ID: 12810707
[TBL] [Abstract][Full Text] [Related]
17. Nuclear receptor, pregname X receptor, is required for induction of UDP-glucuronosyltranferases in mouse liver by pregnenolone-16 alpha-carbonitrile.
Chen C; Staudinger JL; Klaassen CD
Drug Metab Dispos; 2003 Jul; 31(7):908-15. PubMed ID: 12814968
[TBL] [Abstract][Full Text] [Related]
18. Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones.
Bedoucha M; Atzpodien E; Boelsterli UA
J Hepatol; 2001 Jul; 35(1):17-23. PubMed ID: 11495036
[TBL] [Abstract][Full Text] [Related]
19. Glucuronidation of acetaminophen catalyzed by multiple rat phenol UDP-glucuronosyltransferases.
Kessler FK; Kessler MR; Auyeung DJ; Ritter JK
Drug Metab Dispos; 2002 Mar; 30(3):324-30. PubMed ID: 11854153
[TBL] [Abstract][Full Text] [Related]
20. Effect of the acute phase response induced by endotoxin administration on the expression and activity of UGT isoforms in rats.
Alkharfy KM; Poloyac SM; Congiu M; Desmond PV; Frye RF
Drug Metab Lett; 2008 Dec; 2(4):248-55. PubMed ID: 19356101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
